• Imprimeix

Unitat de Nutrició, Ambient i Càncer (UNAC)

La Unitat de Nutrició, Ambient i Càncer (UNAC) està constituïda per un grup multidisciplinari, que integra a epidemiòlegs, estadístics, especialistes en nutrició, informàtics, biòlegs moleculars i genetistes centrats principalment en la investigació etiològica del càncer en l'enquesta Europea sobre Dieta, Càncer i Salut (EPIC) promogut per la Unió Europea i coordinat per l’Agència Internacional de Recerca sobre Càncer (IARC-OMS) i l’Imperial College (Londres).

La Unitat coordina el projecte EPIC a Espanya. L’estratègia científica de l’estudi EPIC es basa en reconèixer que el càncer és un procés complex en el qual actuen múltiples factors ambientals i genètics, i que per avançar en el coneixement científic sobre la relació causal entre l’exposició a la dieta i d’altres factors ambientals i el càncer, es necessita un enfocament innovador que inclogui simultàniament la combinació dels instruments clàssics de l’epidemiologia, amb l’ús de marcadors bioquímics i biològics d’exposició, com també marcadors de susceptibilitat genètica. L’estudi de la interacció dels factors ambientals amb els genètics és una peça clau de l’etiopatogènia.

El Grup encapçala a nivell d’EPIC Europa les investigacions sobre càncer gàstric i d'adenocarcinoma d’esòfag. La UNAC també col·labora estretament amb altres grups d’investigació de EPIC sobre càncer de pulmó, càncer de pròstata, càncer de bufeta i càncer de cèrvix. Un altre àrea que conta amb un nou impuls en els últims anys és la investigació sobre el càncer de pàncrees. La UNAC co-lidera un Consorci Internacional d’estudis cas-control de càncer de pàncrees (PanC4) i és representant del Consorci d'estudis de Cohort EPIC càncer de pàncrees (PANSCAN).

Una altra àrea de recerca dins del grup és en la supervivència del càncer de mama, que està sent investigat dins d'un nou estudi anomenat PREDICOP, un assaig controlat aleatori multicèntric dissenyat per avaluar l'efecte d'una intervenció de l'estil de vida amb una intervenció que combina el control del pes, la dieta i l'activitat física sobre el risc de recurrències en pacients amb càncer de mama.

• Projecte EPIC-EURGAST sobre el càncer d’esòfag i estómac: identificació de factors de risc de susceptibilitat nutricional, ambiental i genètic d'en la població
europea, l’anàlisi de l’expressió gènica i estudis funcionals per caracteritzar la variant causal.
• Identificació dels marcadors en la progressió de les lesions preneoplàsiques de càncer gàstric a Espanya.
• L’exposició endògena i exògena a les nitrosamines, la ingesta de ferro total i grups hemo, l’homeòstasi del ferro, la susceptibilitat genètica i risc de càncer en la població adulta a Europa.
• Biomarcadors d’exposició a l'acrilamida, la susceptibilitat genètica i el risc de càncer d’endometri i d’ovari. La ingesta dietètica d’acrilamida i el risc de càncer de pàncrees i d’esòfag a Europa.
• Reducció de les recurrències del càncer de mama a través del control de pes, la intervenció dietètica i activitat física.

  1. Chuang SC, Fanidi A, Ueland PM, Relton C, Midttun O, Vollset SE, Gunter MJ, Seckl MJ, Travis RC, Wareham N, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Bueno-de-Mesquita HB, Boeing H, Wientzek A, Kuehn T, Kaaks R, Tumino R, Agnoli C, Palli D, Naccarati A, Ardanaz Aicua E, Sanchez MJ, Quiros JR, Chirlaque MD, Agudo A, Johansson M, Grankvist K, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Weiderpass E, Riboli E, Brennan PJ, Vineis P, Johansson M. Circulating biomarkers of tryptophan and the kynurenine pathway and lung càncer risk. Cancer Epidemiol Biomarkers Prev. 2013 Dec 19. Impact Factor: 4.559. Q1: Oncology. Q1: Public, Environmental & Occupational.
  2. Travier N, Fonseca-Nunes A, Javierre C, Guillamo E, Arribas L, Peiró I, Buckland G, Moreno F, Urruticoechea A, Oviedo GR, Roca A, Hurtós L, Ortega V, Muñoz M, Garrigós L, Cirauqui B, Del Barco S, Arcusa A, Seguí MA, Borràs JM, Gonzalez CA, Agudo A. Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors. Med Oncol. 2014 Jan;31(1):783. Impact Factor: 2.147. Q3: Oncology. 
  3. Leenders M, Sluijs I, Ros MM, Boshuizen HC, Siersema PD, Ferrari P, Weikert C, Tjønneland A, Olsen A, Boutron-Ruault MC, Clavel-Chapelon F, Nailler L, Teucher B, Li K, Boeing H, Bergmann MM, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Peeters PH, van Gils CH, Lund E, Engeset D, Redondo ML, Agudo A, Sánchez MJ, Navarro C, Ardanaz E, Sonestedt E, Ericson U, Nilsson LM, Khaw KT, Wareham NJ, Key TJ, Crowe FL, Romieu I, Gunter MJ, Gallo V, Overvad K, Riboli E, Bueno-de-Mesquita HB. Fruit and vegetable consumption and mortality: European prospective investigation into cancer and nutrition. Am J Epidemiol. 2013 Aug 15;178(4):590-602. Impact Factor: 4.780. Q1: Public, Environmental & Occupational Health.
  4. Vergnaud AC, Romaguera D, Peeters PH, van Gils CH, Chan DS, Romieu I, Freisling H, Ferrari P, Clavel-Chapelon F, Fagherazzi G, Dartois L, Li K, Tikk K, Bergmann MM, Boeing H, Tjønneland A, Olsen A, Overvad K, Dahm CC, Redondo ML, Agudo A, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Khaw KT, Wareham NJ, Crowe F, Trichopoulou A, Orfanos P, Trichopoulos D, Masala G, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Ros MM, May A, Wirfält E, Sonestedt E, Johansson I, Hallmans G, Lund E, Weiderpass E, Parr CL, Riboli E, Norat T. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. Am J Clin Nutr. 2013 May;97(5):1107-20. Impact Factor: 6.504. Q1: Nutrition & Dietetics.
  5. Baltar VT, Xun WW, Johansson M, Ferrari P, Chuang SC, Relton C, Ueland PM, Midttun Ø, Slimani N, Jenab M, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Rohrmann S, Boeing H, Weikert C, Bueno-de-Mesquita B, Boshuizen H, van Gils CH, Onland-Moret NC, Agudo A, Barricarte A, Navarro C, Rodríguez L, Castaño JM, Larrañaga N, Khaw KT, Wareham N, Allen NE, Crowe F, Gallo V, Norat T, Krogh V, Masala G, Panico S, Sacerdote C, Tumino R, Trichopoulou A, Lagiou P, Trichopoulos D, Rasmuson T, Hallmans G, Roswall N, Tjønneland A, Riboli E, Brennan P, Vineis P. A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk. Eur J Epidemiol. 2013 Aug;28(8):677-88. Impact Factor: 5.118. Q1: Public, Environmental & Occupational Health.
  6. Vergnaud AC, Norat T, Mouw T, Romaguera D, May AM, Bueno-de-Mesquita HB, van der A D, Agudo A, Wareham N, Khaw KT, Romieu I, Freisling H, Slimani N, Perquier F, Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Berrino F, Mattiello A, Tumino R, Ricceri F, Rodríguez L, Molina-Montes E, Amiano P, Barricarte A, Chirlaque MD, Crowe FL, Orfanos P, Naska A, Trichopoulou A, Teucher B, Kaaks R, Boeing H, Buijsse B, Johansson I, Hallmans G, Drake I, Sonestedt E, Jakobsen MU, Overvad K, Tjønneland A, Halkjær J, Skeie G, Braaten T, Lund E, Riboli E, Peeters PH. Macronutrient composition of the diet and prospective weight change in participants of the EPIC-PANACEA study. PLoS One. 2013;8(3):e57300. Impact Factor: 3.730. Q1: Multidisciplinary Sciences.
  7. Rohrmann S, Linseisen J, Allen N, Bueno-de-Mesquita HB, Johnsen NF, Tjønneland A, Overvad K, Kaaks R, Teucher B, Boeing H, Pischon T, Lagiou P, Trichopoulou A, Trichopoulos D, Palli D, Krogh V, Tumino R, Ricceri F, Argüelles Suárez MV, Agudo A, Sánchez MJ, Chirlaque MD, Barricarte A, Larrañaga N, Boshuizen H, van Kranen HJ, Stattin P, Johansson M, Bjartell A, Ulmert D, Khaw KT, Wareham NJ, Ferrari P, Romieux I, Gunter MJ, Riboli E, Key TJ. Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2013 Feb 19;108(3):708-14. Impact Factor: 5.082. Q1: Oncology.
  8. Jakobsen MU, Dethlefsen C, Due KM, May AM, Romaguera D, Vergnaud AC, Norat T, Sørensen TI, Halkjær J, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Teucher B, Kühn T, Bergmann MM, Boeing H, Naska A, Orfanos P, Trichopoulou A, Palli D, Santucci De Magistris M, Sieri S, Bueno-de-Mesquita HB, van der A DL, Engeset D, Hjartåker A, Rodríguez L, Agudo A, Molina-Montes E, Huerta JM, Barricarte A, Amiano P, Manjer J, Wirfält E, Hallmans G, Johansson I, Khaw KT, Wareham NJ, Key TJ, Chajès V, Slimani N, Riboli E, Peeters PH, Overvad K. Fish consumption and subsequent change in body weight in European women and men. Br J Nutr. 2013 Jan 28;109(2):353-62. Impact Factor: 3.302. Q1: Nutrition & Dietetics. 
  9. Saberi Hosnijeh F, Christopher Y, Peeters P, Romieu I, Xun W, Riboli E, Raaschou-Nielsen O, Tjønneland A, Becker N, Nieters A, Trichopoulou A, Bamia C, Orfanos P, Oddone E, Luján-Barroso L, Dorronsoro M, Navarro C, Barricarte A, Molina-Montes E, Wareham N, Vineis P, Vermeulen R. Occupation and risk of lymphoid and myeloid leukaemia in the European Prospective Investigation into Cancer and Nutrition (EPIC). Occup Environ Med. 2013 Jul;70(7):464-70. Impact Factor: 3.215. Q1: Public, Environmental & Occupational Health.
  10. Zamora-Ros R, Forouhi NG, Sharp SJ, González CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, Fagherazzi G, Feskens EJ, Franks PW, Grioni S, Katzke V, Key TJ, Khaw KT, Kühn T, Masala G, Mattiello A, Molina-Montes E, Nilsson PM, Overvad K, Perquier F, Redondo ML, Ricceri F, Rolandsson O, Romieu I, Roswall N, Scalbert A, Schulze M, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Touillaud M, Tumino R, van der A DL, van Woudenbergh GJ, Langenberg C, Riboli E, Wareham NJ. Dietary Intakes of Individual Flavanols and Flavonols Are Inversely Associated with Incident Type 2 Diabetes in European Populations. J Nutr. 2013 Dec 24. Impact Factor: 4.196. Q1: Nutrition & Dietetics.
  11. Amiano P, Machón M, Dorronsoro M, Dolores Chirlaque M, Barricarte A, Sánchez MJ, Navarro C, Huerta JM, Molina-Montes E, Sánchez-Cantalejo E, Urtizberea M, Arriola L, Larrañaga N, Ardanaz E, Quirós JR, Moreno-Iribas C, González CA. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study. Nutr Metab Cardiovasc Dis. 2013 Dec 19. Impact Factor: 3.978. Q1: Nutrition & Dietetics. Q1: Cardiac & Cardiovascular Systems. Q2: Endocrinology & Metabolism.
  12. Castellsagué X, Pawlita M, Roura E, Margall N, Waterboer T, Bosch FX, de Sanjosé S, Gonzalez CA, Dillner J, Gram IT, Tjønneland A, Munk C, Pala V, Palli D, Khaw KT, Barnabas RV, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Lukanova A, Steffen A, Trichopoulou A, Trichopoulos D, Klinaki E, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Lund E, Weiderpass E, Quirós JR, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Hortlund M, Lindquist D, Wareham N, Travis RC, Rinaldi S, Tommasino M, Franceschi S, Riboli E. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: Evidence from the EPIC cohort. Int J Cancer. 2013 Dec 13. Impact Factor: 6.198. Q1: Oncology.
  13. Buckland G, Ros MM, Roswall N, Bueno-de-Mesquita HB, Travier N, Tjonneland A, Kiemeney LA, Sacerdote C, Tumino R, Ljungberg B, Gram IT, Weiderpass E, Skeie G, Malm J, Ehrnström R, Chang-Claude J, Mattiello A, Agnoli C, Peeters PH, Boutron-Ruault MC, Fagherazzi G, Clavel-Chapelon F, Nilsson LM, Amiano P, Trichopoulou A, Oikonomou E, Tsiotas K, Sánchez MJ, Overvad K, Quirós JR, Chirlaque MD, Barricarte A, Key TJ, Allen NE, Khaw KT, Wareham N, Riboli E, Kaaks R, Boeing H, Palli D, Romieu I, Romaguera D, Gonzalez CA. Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study. Int J Cancer. 2013 Oct 31. Impact Factor: 6.198. Q1: Oncology.
  14. Zamora-Ros R, Forouhi NG, Sharp SJ, González CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, Clavel-Chapelon F, Fagherazzi G, Feskens EJ, Franks PW, Grioni S, Katzke V, Key TJ, Khaw KT, Kühn T, Masala G, Mattiello A, Molina-Montes E, Nilsson PM, Overvad K, Perquier F, Quirós JR, Romieu I, Sacerdote C, Scalbert A, Schulze M, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van der A DL, Langenberg C, Riboli E, Wareham NJ. The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care. 2013 Dec;36(12):3961-70. Impact Factor: 7.735. Q1: Endocrinology & Metabolism.
  15. González CA, Sala N, Rokkas T. Gastric cancer: epidemiologic aspects. Helicobacter. 2013 Sep;18 Suppl 1:34-8. Impact Factor: 3.511. Q2: Gastroenterology & Hepatology. Q2: Microbiology.
  16. Łuczyńska A, Kaaks R, Rohrmann S, Becker S, Linseisen J, Buijsse B, Overvad K, Trichopoulou A, Valanou E, Barmpitsioti A, Masala G, Agnoli C, Tumino R, Panico S, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Vermeulen R, Weiderpass E, Brustad M, Skeie G, González CA, Jakszyn P, Quirós JR, Sánchez MJ, Huerta JM, Ardanaz E, Melin B, Johansson AS, Almquist M, Malm J, Khaw KT, Wareham N, Travis RC, Fedirko V, Romieu I, Jenab M, Gallo V, Riboli E, Vineis P, Nieters A. Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2013 Sep;98(3):827-38. Impact Factor: 6.504. Q1: Nutrition & Dietetics.
  17. Zamora-Ros R, Jiménez C, Cleries R, Agudo A, Sánchez MJ, Sánchez-Cantalejo E, Molina-Montes E, Navarro C, Chirlaque MD, María Huerta J, Amiano P, Redondo ML, Barricarte A, González CA. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology. 2013 Sep;24(5):726-33. Impact Factor: 5.738. Q1: Public, Environmental & Occupational Health.
  18. Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, Tjønneland A, Overvad K, Quirós JR, González CA, Sánchez MJ, Larrañaga N, Navarro C, Barricarte A, Travis RC, Khaw KT, Wareham N, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Panico S, Masala G, Grioni S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Laurell G, Hallmans G, Manjer J, Ekström J, Skeie G, Lund E, Weiderpass E, Ferrari P, Byrnes G, Romieu I, Riboli E, Hildesheim A, Boeing H, Pawlita M, Brennan P. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013 Jul 20;31(21):2708-15. Impact Factor: 18.038. Q1: Oncology.
  19. Duell EJ, Lujan-Barroso L, Llivina C, Muñoz X, Jenab M, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Boeing H, Buijsse B, Canzian F, Johnson T, Dalgård C, Overvad K, Tjønneland A, Olsen A, Sánchez SC, Sánchez-Cantalejo E, Huerta JM,  Ardanaz E, Dorronsoro M, Khaw KT, Travis RC, Trichopoulou A, Trichopoulos D, Rafnsson S, Palli D, Sacerdote C, Tumino R, Panico S, Grioni S, Bueno-de-Mesquita HB, Ros MM, Numans ME, Peeters PH, Johansen D, Lindkvist B, Johansson M, Johansson I, Skeie G, Weiderpass E, Duarte-Salles T, Stenling R, Riboli E, Sala N, González CA. Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort. Genes Nutr. 2013 Nov;8(6):549-60. Impact Factor: 3.329. Q1: Nutrition & Dietetics. Q2: Genetics & Heredity. 
  20. Jakszyn P, Luján-Barroso L, Agudo A, Bueno-de-Mesquita HB, Molina E, Sánchez MJ, Fonseca-Nunes A, Siersema PD, Matiello A, Tumino R, Saieva C, Pala V, Vineis P, Boutron-Ruault MC, Racine A, Bastide N, Travis RC, Khaw KT, Riboli E, Murphy N, Vergnaud AC, Trichopoulou A, Valanou E, Oikonomidou E, Weiderpass E, Skeie G, Johansen D, Lindkvist B, Johansson M, Duarte-Salles T, Freisling H, Barricarte A, Huerta JM, Amiano P, Tjonneland A, Overvad K, Kuehn T, Grote V, Boeing H, Peeters PH, González CA. Meat and heme iron intake and esophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 2013 Dec 1;133(11):2744-50. Impact Factor: 6.198. Q1: Oncology.
  21. Vermeulen E, Zamora-Ros R, Duell EJ, Luján-Barroso L, Boeing H, Aleksandrova K, Bueno-de-Mesquita HB, Scalbert A, Romieu I, Fedirko V, Touillaud M, Fagherazzi G, Perquier F, Molina-Montes E, Chirlaque MD, Vicente Argüelles M, Amiano P, Barricarte A, Pala V, Mattiello A, Saieva C, Tumino R, Ricceri F, Trichopoulou A, Vasilopoulou E, Ziara G, Crowe FL, Khaw KT, Wareham NJ, Lukanova A, Grote VA, Tjønneland A, Halkjær J, Bredsdorff L, Overvad K, Siersema PD, Peeters PH, May AM, Weiderpass E, Skeie G, Hjartåker A, Landberg R, Johansson I, Sonestedt E, Ericson U, Riboli E, González CA. Dietary flavonoid intake and esophageal cancer  risk in the European prospective investigation into cancer and nutrition cohort. Am J Epidemiol. 2013 Aug 15;178(4):570-81. Impact Factor: 4.780. Q1: Public, Environmental & Occupational Health.
  22. Zamora-Ros R, Fedirko V, Trichopoulou A, González CA, Bamia C, Trepo E, Nöthlings U, Duarte-Salles T, Serafini M, Bredsdorff L, Overvad K, Tjønneland A,  Halkjaer J, Fagherazzi G, Perquier F, Boutron-Ruault MC, Katzke V, Lukanova A, Floegel A, Boeing H, Lagiou P, Trichopoulos D, Saieva C, Agnoli C, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Engeset D, Skeie G, Argüelles MV, Molina-Montes E, Dorronsoro M, Tormo MJ, Ardanaz E, Ericson U, Sonestedt E, Sund M, Landberg R, Khaw KT, Wareham NJ, Crowe FL, Riboli E, Jenab M. Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into càncer and nutrition study. Int J Cancer. 2013 Nov 15;133(10):2429-43. Impact Factor: 6.198. Q1: Oncology.
  23. Zamora-Ros R, Knaze V, Romieu I, Scalbert A, Slimani N, Clavel-Chapelon F, Touillaud M, Perquier F, Skeie G, Engeset D, Weiderpass E, Johansson I, Landberg  R, Bueno-de-Mesquita HB, Sieri S, Masala G, Peeters PH, Grote V, Huerta JM, Barricarte A, Amiano P, Crowe FL, Molina-Montes E, Khaw KT, Argüelles MV, Tjønneland A, Halkjær J, de Magistris MS, Ricceri F, Tumino R, Wirfält E, Ericson U, Overvad K, Trichopoulou A, Dilis V, Vidalis P, Boeing H, Förster J, Riboli E, González CA. Impact of thearubigins on the estimation of total dietary flavonoids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Clin Nutr. 2013 Jul;67(7):779-82. Impact Factor: 2.756. Q2: Nutrition & Dietetics.
  24. Zamora-Ros R, Ferrari P, González CA, Tjønneland A, Olsen A, Bredsdorff L, Overvad K, Touillaud M, Perquier F, Fagherazzi G, Lukanova A, Tikk K, Aleksandrova K, Boeing H, Trichopoulou A, Trichopoulos D, Dilis V, Masala G, Sieri S, Mattiello A, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Skeie G, Engeset D, Menéndez V, Travier N, Molina-Montes E, Amiano P, Chirlaque MD, Barricarte A, Wallström P, Sonestedt E, Sund M, Landberg R, Khaw KT, Wareham NJ, Travis RC, Scalbert A, Ward HA, Riboli E, Romieu I. Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Breast Cancer Res Treat. 2013 May;139(1):163-76. Impact Factor: 4.469. Q1: Oncology
  25. Zamora-Ros R, Rothwell JA, Scalbert A, Knaze V, Romieu I, Slimani N, Fagherazzi G, Perquier F, Touillaud M, Molina-Montes E, Huerta JM, Barricarte A, Amiano P, Menéndez V, Tumino R, de Magistris MS, Palli D, Ricceri F, Sieri S, Crowe FL, Khaw KT, Wareham NJ, Grote V, Li K, Boeing H, Förster J, Trichopoulou A, Benetou V, Tsiotas K, Bueno-de-Mesquita HB, Ros M, Peeters PH, Tjønneland A, Halkjær J, Overvad K, Ericson U, Wallström P, Johansson I, Landberg R, Weiderpass E, Engeset D, Skeie G, Wark P, Riboli E, González CA. Dietary intakes and food sources of phenolic acids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 2013 Oct;110(8):1500-11. Impact Factor: 3.302. Q1: Nutrition & Dietetics.
  26. Agudo A, Bonet C, Sala N, Muñoz X, Aranda N, Fonseca-Nunes A, Clavel-Chapelon F, Boutron-Ruault MC, Vineis P, Panico S, Palli D, Tumino R, Grioni S, Quirós JR, Molina E, Navarro C, Barricarte A, Chamosa S, Allen NE, Khaw KT, Bueno-de-Mesquita HB, Siersema PD, Numans ME, Trichopoulou A, Lagiou P, Trichopoulos D, Kaaks R, Canzian F, Boeing H, Meidtner K, Johansson M, Sund M, Manjer J, Overvad K, Tjonneland A, Lund E, Weiderpass E, Jenab M, Fedirko V, Offerhaus GJ, Riboli E, González CA, Jakszyn P. Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis. 2013 Jun;34(6):1244-50. Impact Factor: 5.635. Q1: Oncology.
  27. Huerta JM, Tormo MJ, Chirlaque MD, Gavrila D, Amiano P, Arriola L, Ardanaz E, Rodríguez L, Sánchez MJ, Mendez M, Salmerón D, Barricarte A, Burgui R, Dorronsoro M, Larrañaga N, Molina-Montes E, Moreno-Iribas C, Quirós JR, Toledo E, Travier N, González CA, Navarro C. Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study. BMC Endocr Disord. 2013 Feb 6;13:7. Impact Factor: 2.650. Q3: Endocrinology & Metabolism.
  28. González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013 Sep 1;133(5):1023-32. Impact Factor: 6.198. Q1: Oncology.
  29. Huerta JM, Chirlaque MD, Tormo MJ, Gavrila D, Arriola L, Moreno-Iribas C, Amiano P, Ardanaz E, Barricarte A, Dorronsoro M, Egüés N, Larrañaga N, Molina-Montes E, Quirós JR, Sánchez MJ, González CA, Navarro C. Physical activity and risk of cerebrovascular disease in the European Prospective Investigation into Cancer and Nutrition-Spain study. Stroke. 2013 Jan;44(1):111-8. Impact Factor: 6.158. Q1: Clinical Neurology. Q1: Peripheral Vascular Disease.
  30. Buckland G, Travier N, Cottet V, González CA, Luján-Barroso L, Agudo A, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, May A, Bueno-de-Mesquita HB, Bvan Duijnhoven FJ, Key TJ, Allen N, Khaw KT, Wareham N, Romieu I, McCormack V, Boutron-Ruault M, Clavel-Chapelon F, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Amiano P, Barricarte A, Rodríguez L, Sanchez MJ, Chirlaque MD, Kaaks R, Teucher B, Boeing H, Bergmann MM, Overvad K, Dahm CC, Tjønneland A, Olsen A, Manjer J, Wirfält E, Hallmans G, Johansson I, Lund E, Hjartåker A, Skeie G, Vergnaud AC, Norat T, Romaguera D, Riboli E. Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into càncer and nutrition cohort study. Int J Cancer. 2013 Jun 15;132(12):2918-27. Impact Factor: 6.198. Q1: Oncology.
  31. Agudo A, Bonet C, Travier N, González CA, Vineis P, Bueno-de-Mesquita HB, Trichopoulos D, Boffetta P, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Lukanova A, Schütze M, Boeing H, Tjonneland A, Halkjaer J, Overvad K, Dahm CC, Quirós JR, Sánchez MJ, Larrañaga N, Navarro C, Ardanaz E, Khaw KT, Wareham NJ, Key TJ, Allen NE, Trichopoulou A, Lagiou P, Palli D, Sieri S, Tumino R, Panico S, Boshuizen H, Büchner FL, Peeters PH, Borgquist S, Almquist M, Hallmans G, Johansson I, Gram IT, Lund E, Weiderpass E, Romieu I, Riboli E. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol. 2012 Dec 20;30(36):4550-7. Impact Factor: 18.038. Q1: Oncology.
  32. Zamora-Ros R, Agudo A, Luján-Barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-Mesquita HB, Leenders M, Travis RC, Navarro C, Sánchez-Cantalejo E, Slimani N, Scalbert A, Fedirko V, Hjartåker A, Engeset D, Skeie G, Boeing H, Förster J, Li K, Teucher B, Agnoli C, Tumino R, Mattiello A, Saieva C, Johansson I, Stenling R, Redondo ML, Wallström P, Ericson U, Khaw KT, Mulligan AA, Trichopoulou A, Dilis V, Katsoulis M, Peeters PH, Igali L, Tjønneland A, Halkjær J, Touillaud M, Perquier F, Fagherazzi G, Amiano P, Ardanaz E, Bredsdorff L, Overvad K, Ricceri F, Riboli E, González CA. Dietary flavonoid and lignan intake  and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2012 Dec;96(6):1398-408. Impact Factor: 6.504. Q1: Nutrition & Dietetics.
  33. Zamora-Ros R, Knaze V, Luján-Barroso L, Romieu I, Scalbert A, Slimani N, Hjartåker A, Engeset D, Skeie G, Overvad K, Bredsdorff L, Tjønneland A, Halkjær J, Key TJ, Khaw KT, Mulligan AA, Winkvist A, Johansson I, Bueno-de-Mesquita HB, Peeters PH, Wallström P, Ericson U, Pala V, de Magistris MS, Polidoro S, Tumino R, Trichopoulou A, Dilis V, Katsoulis M, Huerta JM, Martínez V, Sánchez MJ, Ardanaz E, Amiano P, Teucher B, Grote V, Bendinelli B, Boeing H, Förster J, Touillaud M, Perquier F, Fagherazzi G, Gallo V, Riboli E, González CA. Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 2013 Apr 28;109(8):1498-507. Impact Factor: 3.302. Q1: Nutrition & Dietetics.
  34. Travis RC, Appleby PN, Siddiq A, Allen NE, Kaaks R, Canzian F, Feller S, Tjønneland A, Føns Johnsen N, Overvad K, Ramón Quirós J, González CA, Sánchez MJ, Larrañaga N, Chirlaque MD, Barricarte A, Khaw KT, Wareham N, Trichopoulou A, Valanou E, Oustoglou E, Palli D, Sieri S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Stattin P, Ferrari P, Johansson M, Norat T, Riboli E, Key TJ. Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition. Int J Cancer. 2013 Apr 15;132(8):1901-10. Impact Factor: 6.198. Q1: Oncology.
  35. Cirera L, Huerta JM, Chirlaque MD, Buckland G, Larrañaga N, Sánchez MJ, Agudo A, Amiano P, Quirós JR, Ardanaz E, Arriola L, Molina E, Dorronsoro M, Barricarte A, González CA, Moreno-Iribas C, Navarro C. Unfavourable life-course social gradient of coronary heart disease within Spain: a low-incidence welfare-state country. Int J Public Health. 2013 Feb;58(1):65-77. Impact Factor: 1.993. Q2: Public, Environmental & Occupational Health.
  36. Machón M, Arriola L, Larrañaga N, Amiano P, Moreno-Iribas C, Agudo A, Ardanaz E, Barricarte A, Buckland G, Chirlaque MD, Gavrila D, Huerta JM, Martínez C, Molina E, Navarro C, Quiros JR, Rodríguez L, Sanchez MJ, González CA, Dorronsoro M. Validity of self-reported prevalent cases of stroke and acute myocardial infarction in the Spanish cohort of the EPIC study. J Epidemiol Community Health. 2013 Jan;67(1):71-5. Impact Factor: 3.392. Q1: Public, Environmental & Occupational Health.
  37. Hogervorst J, Duell EJ, Schouten L, Slimani N, van den Brandt P. Reaction on the acrylamide and cancer review by Lipworth and colleagues. Eur J Cancer Prev. 2013 Mar;22(2):194-8. Impact Factor: 2.974. Q2: Oncology.
  38. Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Peterson G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: A gene and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014 Jan 13. Impact Factor: 5.635. Q1: Oncology.
  39. Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen GM, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D. Genes-Environment Interactions in Obesity- and Diabetes-Associated Pancreatic Cancer: A GWAS Data Analysis. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):98-106. Impact Factor: 4.559. Q1: Oncology. Q1: Public, Environmental & Occupational.
  40. Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F, Cao G, Duell EJ, Elena JW, Gaziano JM, Giovannucci EL, Hallmans G, Hutchinson A, Hunter DJ, Jenab M, Jiang G, Khaw KT, Lacroix A, Li Z, Mendelsohn JB, Panico S, Patel AV, Qian ZR, Riboli E, Sesso H, Shen H, Shu XO, Tjonneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Wactawski-Wende J, Wang C, Yu K, Zeleniuch-Jacquotte A, Chanock S, Hoover R, Hartge P, Fuchs CS, Lin D, Wolpin BM. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut. 2014 Jan;63(1):152-60. Impact Factor: 10.732. Q1: Gastroenterology & Hepatology.
  41. Bonifaci N, Colas E, Serra-Musach J, Karbalai N, Brunet J, Gómez A, Esteller M, Fernández-Taboada E, Berenguer A, Reventós J, Müller-Myhsok B, Amundadottir L, Duell EJ, Pujana MA. Integrating gene expression and epidemiological data for the discovery of genetic interactions associated with cancer risk. Carcinogenesis. 2014 Jan 2. Impact Factor: 5.635. Q1: Oncology.
  42. Duell EJ, Travier N, Lujan-Barroso L, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Tumino R, Masala G, Krogh V, Panico S, Ricceri F, Redondo ML, Dorronsoro M, Molina-Montes E, Huerta JM, Barricarte A, Khaw KT, Wareham NJ, Allen NE, Travis R, Siersema PD, Peeters PH, Trichopoulou A, Fragogeorgi E, Oikonomou E, Boeing H, Schuetze M, Canzian F, Lukanova A, Tjønneland A, Roswall N, Overvad K, Weiderpass E, Gram IT, Lund E, Lindkvist B, Johansen D, Ye W, Sund M, Fedirko V, Jenab M, Michaud DS, Riboli E, Bueno-de-Mesquita HB. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int J Cancer. 2013 May 1;132(9):2164-75. Impact Factor: 6.198. Q1: Oncology.
  43. Bergmann MM, Rehm J, Klipstein-Grobusch K, Boeing H, Schütze M, Drogan D, Overvad K, Tjønneland A, Halkjær J, Fagherazzi G, Boutron-Ruault MC, Clavel-Chapelon F, Teucher B, Kaaks R, Trichopoulou A, Benetou V, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Beulens JW, Redondo ML, Duell EJ, Molina-Montes E, Navarro C, Barricarte A, Arriola L, Allen NE, Crowe FL, Khaw KT, Wareham N, Romaguera D, Wark PA, Romieu I, Nunes L, Riboli E, Ferrari P. The association of pattern of lifetime alcohol use and cause of death in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol. 2013 Dec;42(6):1772-90. Impact Factor: 6.982. Q1: Public, Environmental & Occupational Health.
  44. Andersen DK, Andren-Sandberg Å, Duell EJ, Goggins M, Korc M, Petersen GM, Smith JP, Whitcomb DC. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas. 2013 Nov;42(8):1227-37. Impact Factor: 2.953. Q2: Gastroenterology & Hepatology.
  45. Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, Duell EJ, Elena J, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hassan M, Hutchinson A, Hunter DJ, Kooperberg C, Kurtz RC, Liu S, Overvad K, Palli D, Patel AV, Rabe KG, Shu XO, Slimani N, Tobias GS, Trichopoulos D, Van Den Eeden SK, Vineis P, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hoover RN, Hartge P, Kraft P. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013 Sep 13;8(9):e72311. Impact Factor: 3.730. Q1: Multidisciplinary Sciences.
  46. Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, Brenner H, Müller H, Harris CC, Duell EJ, Andrew AS, McLaughlin JR, Schwartz AG, Wenzlaff AS, Stucker I. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer. 2013 Oct 1;109(7):1954-64. Impact Factor: 5.082. Q1: Oncology.
  47. Bosetti C, Lucenteforte E, Bracci PM, Negri E, Neale RE, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Holly EA, Gao YT, Yu H, Kurtz RC, Cotterchio M, Maisonneuve P, Zeegers MP, Duell EJ, Boffetta P, La Vecchia C. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2013 Nov;24(11):2903-10. Impact Factor: 7.384. Q1: Oncology.
  48. Michaud DS, Izard J, Rubin Z, Johansson I, Weiderpass E, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Katzke VA, Boeing H, Foerster J, Trichopoulou A, Naska A, Ziara G, Vineis P, Grioni S, Palli D, Tumino R, Mattiello A, Peeters PH, Siersema PD, Barricarte A, Huerta JM, Molina-Montes E, Dorronsoro M, Quirós JR, Duell EJ, Ohlsson B, Jeppsson B, Johansson A, Lif P, Khaw KT, Wareham N, Travis RC, Key TJ, Freisling H, Duarte-Salles T, Stepien M, Riboli E, Bueno-de-Mesquita HB. Lifestyle, dietary factors, and antibody levels to oral bacteria in cancer-free participants of a European cohort study. Cancer Causes Control. 2013 Nov;24(11):1901-9. Impact Factor: 3.200. Q1: Public, Environmental & Occupational Health. Q2: Oncology.
  49. Obón-Santacana M, Slimani N, Lujan-Barroso L, Travier N, Hallmans G, Freisling H, Ferrari P, Boutron-Ruault MC, Racine A, Clavel F, Saieva C, Pala V, Tumino R, Mattiello A, Vineis P, Argüelles M, Ardanaz E, Amiano P, Navarro C, Sánchez MJ, Molina Montes E, Key T, Khaw KT, Wareham N, Peeters PH, Trichopoulou A, Bamia C, Trichopoulos D, Boeing H, Kaaks R, Katzke V, Ye W, Sund M, Ericson U, Wirfält E, Overvad K, Tjønneland A, Olsen A, Skeie G, Åsli LA, Weiderpass E, Riboli E, Bueno-de-Mesquita HB, Duell EJ. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Ann Oncol. 2013 Oct;24(10):2645-51. Impact Factor: 7.384. Q1: Oncology.
  50. Olson SH, Hsu M, Satagopan JM, Maisonneuve P, Silverman DT, Lucenteforte E, Anderson KE, Borgida A, Bracci PM, Bueno-de-Mesquita HB, Cotterchio M, Dai Q, Duell EJ, Fontham EH, Gallinger S, Holly EA, Ji BT, Kurtz RC, La Vecchia C, Lowenfels AB, Luckett B, Ludwig E, Petersen GM, Polesel J, Seminara D, Strayer L, Talamini R; Pancreatic Cancer Case-Control Consortium. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Am J Epidemiol. 2013 Sep 1;178(5):691-700. Impact Factor: 4.780. Q1: Public, Environmental & Occupational Health.
  51. Bhoo-Pathy N, Uiterwaal CS, Dik VK, Jeurnink SM, Bech BH, Overvad K, Halkjær J, Tjønneland A, Boutron-Ruault MC, Fagherazzi G, Racine A, Katzke VA, Li K, Boeing H, Floegel A, Androulidaki A, Bamia C, Trichopoulou A, Masala G, Panico S, Crosignani P, Tumino R, Vineis P, Peeters PH, Gavrilyuk O, Skeie G, Weiderpass E, Duell EJ, Arguelles M, Molina-Montes E, Navarro C, Ardanaz E, Dorronsoro M, Lindkvist B, Wallström P, Sund M, Ye W, Khaw KT, Wareham N, Key TJ, Travis RC, Duarte-Salles T, Freisling H, Licaj I, Gallo V, Michaud DS, Riboli E, Bueno-De-Mesquita HB. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1486-92. Impact Factor: 6.648. Q1: Gastroenterology & Hepatology.
  52. Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol. 2013 Aug;133(8):1950-5. Impact Factor: 6.193. Q1: Dermatology.
  53. Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Kooperberg C, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen G, Risch HA, Yu K, Wolpin BM, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovanucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman-Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Tjønneland A, Trichopoulos D, Virtamo J, Visvanathan K, Elena JW, Yu H, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ.  Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control. 2013 Mar;24(3):595-602. Impact Factor: 3.200. Q1: Public, Environmental & Occupational Health. Q2: Oncology.
  54. Fedirko V, Jenab M, Rinaldi S, Biessy C, Allen NE, Dossus L, Onland-Moret NC, Schütze M, Tjønneland A, Hansen L, Overvad K, Clavel-Chapelon F, Chabbert-Buffet N, Kaaks R, Lukanova A, Bergmann MM, Boeing H, Trichopoulou A, Oustoglou E, Barbitsioti A, Saieva C, Tagliabue G, Galasso R, Tumino R, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Gram IT, Sanchez S, Duell EJ, Molina-Montes E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Lundin E, Idahl A, Khaw KT, Romaguera-Bosch D, Wark PA, Norat T, Romieu I. Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Ann Epidemiol. 2013 Feb;23(2):93-8. Impact Factor: 2.479. Q1: Public, Environmental & Occupational Health.
  55. Freisling H, Moskal A, Ferrari P, Nicolas G, Knaze V, Clavel-Chapelon F, Boutron-Ruault MC, Nailler L, Teucher B, Grote VA, Boeing H, Clemens M, Tjønneland A, Olsen A, Overvad K, Quirós JR, Duell EJ, Sánchez MJ, Amiano P, Chirlaque MD, Barricarte A, Khaw KT, Wareham NJ, Crowe FL, Gallo V, Oikonomou E, Naska A, Trichopoulou A, Palli D, Agnoli C, Tumino R, Polidoro S, Mattiello A, Bueno-de-Mesquita HB, Ocké MC, Peeters PH, Wirfält E, Ericson U, Bergdahl IA, Johansson I, Hjartåker A, Engeset D, Skeie G, Riboli E, Slimani N. Dietary acrylamide intake of adults in the European Prospective Investigation into Cancer and Nutrition differs greatly according to geographical region. Eur J Nutr. 2013 Jun;52(4):1369-80. Impact Factor: 3.127. Q2: Nutrition & Dietetics.
  56. Brand JS, van der Schouw YT, Onland-Moret NC, Sharp SJ, Ong KK, Khaw KT, Ardanaz E, Amiano P, Boeing H, Chirlaque MD, Clavel-Chapelon F, Crowe FL, de Lauzon-Guillain B, Duell EJ, Fagherazzi G, Franks PW, Grioni S, Groop LC, Kaaks R, Key TJ, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Sacerdote C, Sánchez MJ, Slimani N, Teucher B, Tjonneland A, Tumino R, van der A DL, Feskens EJ, Langenberg C, Forouhi NG, Riboli E, Wareham NJ; InterAct Consortium. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. Diabetes Care. 2013 Apr;36(4):1012-9. Impact Factor: 7.735. Q1: Endocrinology & Metabolism.
  57. Ferrari P, Freisling H, Duell EJ, Kaaks R, Lujan-Barroso L, Clavel-Chapelon F, Boutron-Ruault MC, Nailler L, Polidoro S, Mattiello A, Palli D, Tumino R, Grioni S, Knüppel S, Tjønneland A, Olsen A, Overvad K, Orfanos P, Katsoulis M, Trichopoulou A, Quirós JR, Ardanaz E, Huerta JM, Etxezarreta PA, Sánchez MJ, Crowe F, Khaw KT, Wareham NJ, Ocke M, Bueno-de-Mesquita B, Peeters PH, Ericson U, Wirfält E, Hallmans G, Johansson I, Engeset D, Nicolas G, Gallo V, Norat T, Riboli E, Slimani N. Challenges in estimating the validity of dietary acrylamide  measurements. Eur J Nutr. 2013 Aug;52(5):1503-12. Impact Factor: 3.127. Q2: Nutrition & Dietetics.
  58. Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, Hallmans G, Howard BV, Hunter DJ, Hutchinson A, Jacobs KB, Kooperberg C, Kraft P, Mendelsohn JB, Michaud DS, Palli D, Phillips LS, Overvad K, Patel AV, Sansbury L, Shu XO, Simon MS, Slimani N, Trichopoulos D, Visvanathan K, Virtamo J, Wolpin BM, Zeleniuch-Jacquotte A, Fuchs CS, Hoover RN, Gross M. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control. 2013 Jan;24(1):13-25. Impact Factor: 3.200. Q1: Public, Environmental & Occupational Health. Q2: Oncology.
  59. Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M, Fedirko V, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R, Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD, Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E, Dorronsoro M, Quirós JR, Duell EJ, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Bueno-de-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013 Dec;62(12):1764-70. Impact Factor: 10.732. Q1: Gastroenterology & Hepatology.
  60. Rohrmann S, Linseisen J, Nöthlings U, Overvad K, Egeberg R, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Cottet V, Pala V, Tumino R, Palli D, Panico S, Vineis P, Boeing H, Pischon T, Grote V, Teucher B, Khaw KT, Wareham NJ, Crowe FL, Goufa I, Orfanos P, Trichopoulou A, Jeurnink SM, Siersema PD, Peeters PH, Brustad M, Engeset D, Skeie G, Duell EJ, Amiano P, Barricarte A, Molina-Montes E, Rodríguez L, Tormo MJ, Sund M, Ye W, Lindkvist B, Johansen D, Ferrari P, Jenab M, Slimani N, Ward H, Riboli E, Norat T, Bueno-de-Mesquita HB. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013 Feb 1;132(3):617-24. Impact Factor: 6.198. Q1: Oncology.
  61. Fedirko V, Trichopolou A, Bamia C, Duarte-Salles T, Trepo E, Aleksandrova K, Nöthlings U, Lukanova A, Lagiou P, Boffetta P, Trichopoulos D, Katzke VA, Overvad K, Tjønneland A, Hansen L, Boutron-Ruault MC, Fagherazzi G, Bastide N, Panico S, Grioni S, Vineis P, Palli D, Tumino R, Bueno-de-Mesquita HB, Peeters PH, Skeie G, Engeset D, Parr CL, Jakszyn P, Sánchez MJ, Barricarte A, Amiano P, Chirlaque M, Quirós JR, Sund M, Werner M, Sonestedt E, Ericson U, Key TJ, Khaw KT, Ferrari P, Romieu I, Riboli E, Jenab M. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and  Nutrition (EPIC). Ann Oncol. 2013 Aug;24(8):2166-73. Impact Factor: 7.384. Q1: Oncology.
  62. Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland A, Nailler L, Boutron-Ruault MC, Clavel-Chapelon F, Krogh V, Palli D, Panico S, Tumino R, Ricceri F, Bergmann MM, Boeing H, Li K, Kaaks R, Khaw KT, Wareham NJ, Crowe FL, Key TJ, Naska A, Trichopoulou A, Trichopoulos D, Leenders M, Peeters PH, Engeset D, Parr CL, Skeie G, Jakszyn P, Sánchez MJ, Huerta JM, Redondo ML, Barricarte A, Amiano P, Drake I, Sonestedt E, Hallmans G, Johansson I, Fedirko V, Romieux I, Ferrari P, Norat T, Vergnaud AC, Riboli E, Linseisen J. Meat consumption and mortality--results from the European Prospective Investigation into Cancer and Nutrition. BMC Med. 2013 Mar 7;11:63. Impact Factor: 6.679. Q1: Medicine, General & Internal.
  63. Keszei AP, Goldbohm RA, Schouten LJ, Jakszyn P, van den Brandt PA. Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am J Clin Nutr. 2013 Jan;97(1):135-46. Impact Factor: 6.504. Q1: Nutrition & Dietetics.
  64. Allen NE, Appleby PN, Key TJ, Bueno-de-Mesquita HB, Ros MM, Kiemeney LA, Tjønneland A, Roswall N, Overvad K, Weikert S, Boeing H, Chang-Claude J, Teucher B, Panico S, Sacerdote C, Tumino R, Palli D, Sieri S, Peeters P, Quirós JR, Jakszyn P, Molina-Montes E, Chirlaque MD, Ardanaz E, Dorronsoro M, Khaw KT, Wareham N, Ljungberg B, Hallmans G, Ehrnström R, Ericson U, Gram IT, Parr CL, Trichopoulou A, Karapetyan T, Dilis V, Clavel-Chapelon F, Boutron-Ruault MC, Fagherrazzi G, Romieu I, Gunter MJ, Riboli E. Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into càncer and nutrition. Int J Cancer. 2013 Feb 1;132(3):635-44. Impact Factor: 6.198. Q1: Oncology.
  65. Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, Van Duijnhoven FJ, Cauchi S, Yengo L, Froguel P, Overvad K, Bech BH, Tjønneland A, Olsen A, Boutron-Ruault MC, Racine A, Fagherazzi G, Kühn T, Campa D, Boeing H, Aleksandrova K, Trichopoulou A, Peppa E, Oikonomou E, Palli D, Grioni S, Vineis P, Tumino R, Panico S, Peeters PH, Weiderpass E, Engeset D, Braaten T, Dorronsoro M, Chirlaque MD, Sánchez MJ, Barricarte A, Zamora-Ros R, Argüelles M, Jirström K, Wallström P, Nilsson LM, Ljuslinder I, Travis RC, Khaw KT, Wareham N, Freisling H, Licaj I, Jenab M, Gunter MJ, Murphy N, Romaguera-Bosch D, Riboli E. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study. Int J Cancer. 2013 Dec 7. Impact Factor: 6.198. Q1: Oncology.
  66. Abbas S, Linseisen J, Rohrmann S, Beulens JW, Buijsse B, Amiano P, Ardanaz E, Balkau B, Boeing H, Clavel-Chapelon F, Fagherazzi G, Franks PW, Gavrila D, Grioni S, Kaaks R, Key TJ, Khaw KT, Kühn T, Mattiello A, Molina-Montes E, Nilsson PM, Overvad K, Quirós JR, Rolandsson O, Sacerdote C, Saieva C, Slimani N, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, Zamora-Ros R, Sharp SJ, Langenberg C, Forouhi NG, Riboli E, Wareham NJ. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. Eur J Clin Nutr. 2013 Nov 20. Impact Factor: 2.756. Q2: Nutrition & Dietetics.
  67. Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, Olsen A, Tjønneland A, Dahm CC, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Nailler L, Kaaks R, Teucher B, Boeing H, Bergmann MM, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Panico S, Peeters PH, Dik VK, Weiderpass E, Lund E, Garcia JR, Zamora-Ros R, Pérez MJ, Dorronsoro M, Navarro C, Ardanaz E, Manjer J, Almquist M, Johansson I, Palmqvist R, Khaw KT, Wareham N, Key TJ, Crowe FL, Fedirko V, Gunter MJ, Riboli E. Consumption of dairy products and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS One. 2013 Sep 2;8(9):e72715. Impact Factor: 3.730. Q1: Multidisciplinary Sciences.
  68. Zamora-Ros R, Rabassa M, Cherubini A, Urpí-Sardà M, Bandinelli S, Ferrucci L, Andres-Lacueva C. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults. J Nutr. 2013 Sep;143(9):1445-50. Impact Factor: 3.127. Q2: Nutrition & Dietetics.
  69. Schlesinger S, Aleksandrova K, Pischon T, Jenab M, Fedirko V, Trepo E, Overvad K, Roswall N, Tjønneland A, Boutron-Ruault MC, Fagherazzi G, Racine A, Kaaks R, Grote VA, Boeing H, Trichopoulou A, Pantzalis M, Kritikou M, Mattiello A, Sieri S, Sacerdote C, Palli D, Tumino R, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Quirós JR, Zamora-Ros R, Sánchez MJ, Arriola L, Ardanaz E, Tormo MJ, Nilsson P, Lindkvist B, Sund M, Rolandsson O, Khaw KT, Wareham N, Travis RC, Riboli E, Nöthlings U. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol. 2013 Sep;24(9):2449-55. Impact Factor: 7.384. Q1: Oncology.
  70. Zamora-Ros R, Serafini M, Estruch R, Lamuela-Raventós RM, Martínez-González MA, Salas-Salvadó J, Fiol M, Lapetra J, Ar��s F, Covas MI, Andres-Lacueva C; PREDIMED Study Investigators. Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED study: Evidence for a mechanism of antioxidant tuning. Nutr Metab Cardiovasc Dis. 2013 Dec;23(12):1167-74. Impact Factor: 3.978. Q1: Nutrition & Dietetics. Q1: Cardiac & Cardiovascular Systems. Q2: Endocrinology & Metabolism.
  71. Eussen SJ, Nilsen RM, Midttun Ø, Hustad S, IJssennagger N, Meyer K, Fredriksen Å, Ulvik A, Ueland PM, Brennan P, Johansson M, Bueno-de-Mesquita B, Vineis P, Chuang SC, Boutron-Ruault MC, Dossus L, Perquier F, Overvad K, Teucher B, Grote VA, Trichopoulou A, Adarakis G, Plada M, Sieri S, Tumino R, de Magistris MS, Ros MM, Peeters PH, Redondo ML, Zamora-Ros R, Chirlaque MD, Ardanaz E, Sonestedt E, Ericson U, Schneede J, van Guelpen B, Wark PA, Gallo V, Norat T, Riboli E, Vollset SE. North-south gradients in plasma concentrations of B-vitamins and other components of one-carbon metabolism in Western Europe: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Br J Nutr. 2013 Jul 28;110(2):363-74. Impact Factor: 3.302. Q1: Nutrition & Dietetics.
  72. Fedirko V, Lukanova A, Bamia C, Trichopolou A, Trepo E, Nöthlings U, Schlesinger S, Aleksandrova K, Boffetta P, Tjønneland A, Johnsen NF, Overvad K, Fagherazzi G, Racine A, Boutron-Ruault MC, Grote V, Kaaks R, Boeing H, Naska A, Adarakis G, Valanou E, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Weiderpass E, Skeie G, Engeset D, Quirós JR, Zamora-Ros R, Sánchez MJ, Amiano P, Huerta JM, Barricarte A, Johansen D, Lindkvist B, Sund M, Werner M, Crowe F, Khaw KT, Ferrari P, Romieu I, Chuang SC, Riboli E, Jenab M. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol. 2013 Feb;24(2):543-53. Impact Factor: 7.384. Q1: Oncology.
  73. Recarte-Pelz P, Tàssies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, de Frutos PG. Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res Ther. 2013 Mar 12;15(2):R41. Impact Factor: 4.302. Q1: Rheumatology.
  74. Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, Vahdaninia M, Grote V, Kaaks R, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Travis RC, Petersson J, Hansson O, Arriola L, Jimenez-Martin JM, Tjønneland A, Halkjær J, Agnoli C, Sacerdote C, Bonet C, Trichopoulou A, Gavrila D, Overvad K, Weiderpass E, Palli D, Quirós JR, Tumino R, Khaw KT, Wareham N, Barricante-Gurrea A, Fedirko V, Ferrari P, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Vigl M, Middleton L, Riboli E, Vineis P. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013 Feb 26;80(9):829-38. Impact Factor: 8.249. Q1: Clinical Neurology.
  75. Saberi Hosnijeh F, Romieu I, Gallo V, Riboli E, Tjønneland A, Halkjær J, Fagherazzi G, Clavel-Chapelon F, Dossus L, Lukanova A, Kaaks R, Trichopoulou A, Lagiou P, Katsoulis M, Panico S, Tagliabue G, Bonet C, Dorronsoro M, Huerta JM, Ardanaz E, Sánchez MJ, Johansen D, Borgquist S, Peeters P, Bueno-de-Mesquita HB, Ros MM, Travis RC, Key TJ, Vineis P, Vermeulen R. Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2013 Mar;24(3):427-38. Impact Factor: 3.200. Q1: Public, Environmental & Occupational Health. Q2: Oncology.
  76. Ritte R, Tikk K, Lukanova A, Tjønneland A, Olsen A, Overvad K, Dossus L, Fournier A, Clavel-Chapelon F, Grote V, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Weiderpass E, Dumeaux V, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, Vineis P, Merritt MA, Riboli E, Kaaks R. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer. 2013 Dec 9;13:584. Impact Factor: 3.333. Q2: Oncology.
  77. Kaaks R, Johnson T, Tikk K, Sookthai D, Tjønneland A, Roswall N, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Rinaldi S, Romieu I, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Tumino R, Sacerdote C, Panico S, Buckland G, Argüelles M, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Torhild Gram I, Lund E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A. Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort. Int J Cancer. 2013 Nov 7. Impact Factor: 6.198. Q1: Oncology.
  78. Buckland G, Ros MM, Roswall N, Bueno-de-Mesquita HB, Travier N, Tjonneland A, Kiemeney LA, Sacerdote C, Tumino R, Ljungberg B, Gram IT, Weiderpass E, Skeie G, Malm J, Ehrnström R, Chang-Claude J, Mattiello A, Agnoli C, Peeters PH, Boutron-Ruault MC, Fagherazzi G, Clavel-Chapelon F, Nilsson LM, Amiano P, Trichopoulou A, Oikonomou E, Tsiotas K, Sánchez MJ, Overvad K, Quirós JR, Chirlaque MD, Barricarte A, Key TJ, Allen NE, Khaw KT, Wareham N, Riboli E, Kaaks R, Boeing H, Palli D, Romieu I, Romaguera D, Gonzalez CA. Adherence to the Mditerranean diet and risk of bladder cancer in the EPIC cohort study. Int J Cancer. 2013 Oct 31. Impact Factor: 6.198. Q1: Oncology.
  79. Kaaks R, Tikk K, Sookthai D, Schock H, Johnson T, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Dossus L, Baglietto L, Rinaldi S, Chajes V, Romieu I, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Ricceri F, Mattiello A, Buckland G, Ramón Quirós J, Sánchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bas Bueno-de-Mesquita H, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort. Int J Cancer. 2013 Oct 8. Impact Factor: 6.198. Q1: Oncology.
  80. Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, Dahm CC, Overvad K, Olsen A, Tjønneland A, Cottet V, Boutron-Ruault MC, Morois S, Grote V, Teucher B, Boeing H, Buijsse B, Trichopoulos D, Adarakis G, Tumino R, Naccarati A, Panico S, Palli D, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Engeset D, Skeie G, Lund E, Sánchez MJ, Barricarte A, Huerta JM, Quirós JR, Dorronsoro M, Ljuslinder I, Palmqvist R, Drake I, Key TJ, Khaw KT, Wareham N, Romieu I, Fedirko V, Jenab M, Romaguera D, Norat T, Trichopoulou A. Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol. 2013 Apr;28(4):317-28. Impact Factor: 5.118. Q1: Public, Environmental & Occupational Health.
  81. Kühn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, Kvaskoff M, Dossus L, Tjønneland A, Olsen A, Overvad K, Chang-Claude J, Lukanova A, Buijsse B, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Krogh V, Sacerdote C, Tumino R, Mattiello A, Buckland G, Sánchez MJ, Menéndez V, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Bakker MF, Weiderpass E, Skeie G, Brustad M, Andersson A, Sund M, Wareham N, Khaw KT, Travis RC, Schmidt JA, Rinaldi S, Romieu I, Gallo V, Murphy N, Riboli E, Linseisen J. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int J Cancer. 2013 Oct 1;133(7):1689-700. Impact Factor: 6.198. Q1: Oncology.
  82. Abbas S, Linseisen J, Rohrmann S, Chang-Claude J, Peeters PH, Engel P, Brustad M, Lund E, Skeie G, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Kaaks R, Boeing H, Buijsse B, Adarakis G, Ouranos V, Trichopoulou A, Masala G, Krogh V, Mattiello A, Tumino R, Sacerdote C, Buckland G, Suárez MV, Sánchez MJ, Chirlaque MD, Barricarte A, Amiano P, Manjer J, Wirfält E, Lenner P, Sund M, Bueno-de-Mesquita HB, van Duijnhoven FJ, Khaw KT, Wareham N, Key TJ, Fedirko V, Romieu I, Gallo V, Norat T, Wark PA, Riboli E. Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Nutr Cancer. 2013;65(2):178-87. Impact Factor: 2.695. Q2: Nutrition & Dietetics. Q2: Oncology.
  83. Ferrari P, Rinaldi S, Jenab M, Lukanova A, Olsen A, Tjønneland A, Overvad K, Clavel-Chapelon F, Fagherazzi G, Touillaud M, Kaaks R, von Rüsten A, Boeing H, Trichopoulou A, Lagiou P, Benetou V, Grioni S, Panico S, Masala G, Tumino R, Polidoro S, Bakker MF, van Gils CH, Ros MM, Bueno-de-Mesquita HB, Krum-Hansen S, Engeset D, Skeie G, Pilar A, Sánchez MJ, Buckland G, Ardanaz E, Chirlaque D, Rodriguez L, Travis R, Key T, Khaw KT, Wareham NJ, Sund M, Lenner P, Slimani N, Norat T, Aune D, Riboli E, Romieu I. Dietary fiber intake and risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2013 Feb;97(2):344-53. Impact Factor: 6.504. Q1: Nutrition & Dietetics.
  84. Sluijs I, Beulens JW, van der Schouw YT, van der A DL, Buckland G, Kuijsten A, Schulze MB, Amiano P, Ardanaz E, Balkau B, Boeing H, Gavrila D, Grote VA, Key TJ, Li K, Nilsson P, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Sieri S, Slimani N, Spijkerman AM, Tjønneland A, Tumino R, Sharp SJ, Langenberg C, Feskens EJ, Forouhi NG, Riboli E, Wareham NJ; InterAct consortium. Dietary glycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries. J Nutr. 2013 Jan;143(1):93-9. Impact Factor: 3.127. Q2: Nutrition & Dietetics.
  85. Ritte R, Lukanova A, Tjønneland A, Olsen A, Overvad K, Mesrine S, Fagherazzi G, Dossus L, Teucher B, Steindorf K, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita B, van Duijnhoven F, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Krum-Hansen S, Gram IT, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, McCormack V, Riboli E, Kaaks R. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer. 2013 Jun 1;132(11):2619-29. Impact Factor: 6.198. Q1: Oncology.
  86. Steffen A, Sørensen TI, Knüppel S, Travier N, Sánchez MJ, Huerta JM, Quirós JR, Ardanaz E, Dorronsoro M, Teucher B, Li K, Bueno-de-Mesquita HB, van der A D, Mattiello A, Palli D, Tumino R, Krogh V, Vineis P, Trichopoulou A, Orfanos P, Trichopoulos D, Hedblad B, Wallström P, Overvad K, Halkjær J, Tjønneland A, Fagherazzi G, Dartois L, Crowe F, Khaw KT, Wareham N, Middleton L, May AM, Peeters PH, Boeing H. Development and validation of a risk score predicting substantial weight gain over 5 years in middle-aged European men and women. PLoS One. 2013 Jul 16;8(7):e67429. Impact Factor: 3.730. Q1: Multidisciplinary Sciences.
  87. Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, Tjonneland A, Hansen L, Overvad K, Chabbert-Buffet N, Mesrine S, Clavel-Chapelon F, Teucher B, Chang-Claude J, Boeing H, Drogan D, Trichopoulou A, Benetou V, Bamia C, Palli D, Agnoli C, Galasso R, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Onland-Moret NC, Redondo ML, Travier N, Sanchez MJ, Altzibar JM, Chirlaque MD, Barricarte A, Lundin E, Khaw KT, Wareham N, Fedirko V, Romieu I, Romaguera D, Norat T, Riboli E, Kaaks R. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. Am J Epidemiol. 2013 Apr 15;177(8):787-99. Impact Factor: 4.780. Q1: Public, Environmental & Occupational Health.
  88. Steindorf K, Ritte R, Eomois PP, Lukanova A, Tjonneland A, Johnsen NF, Overvad K, Østergaard JN, Clavel-Chapelon F, Fournier A, Dossus L, Teucher B, Rohrmann S, Boeing H, Wientzek A, Trichopoulou A, Karapetyan T, Trichopoulos D, Masala G, Berrino F, Mattiello A, Tumino R, Ricceri F, Quirós JR, Travier N, Sánchez MJ, Navarro C, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Duijnhoven F, Monninkhof E, May AM, Khaw KT, Wareham N, Key TJ, Travis RC, Borch KB, Sund M, Andersson A, Fedirko V, Rinaldi S, Romieu I, Wahrendorf J, Riboli E, Kaaks R. Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition. Int J Cancer. 2013 Apr 1;132(7):1667-78. Impact Factor: 6.198. Q1: Oncology.
  89. Schlesinger S, Aleksandrova K, Pischon T, Fedirko V, Jenab M, Trepo E, Boffetta P, Dahm CC, Overvad K, Tjønneland A, Halkjær J, Fagherazzi G, Boutron-Ruault MC, Carbonnel F, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Bamia C, Lagiou P, Palli D, Grioni S, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, van den Berg S, Peeters PH, Braaten T, Weiderpass E, Quirós JR, Travier N, Sánchez MJ, Navarro C, Barricarte A, Dorronsoro M, Lindkvist B, Regner S, Werner M, Sund M, Khaw KT, Wareham N, Travis RC, Norat T, Wark PA, Riboli E, Nöthlings U. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer. 2013 Feb 1;132(3):645-57. Impact Factor: 6.198. Q1: Oncology. 
  90. Elks CE, Ong KK, Scott RA, van der Schouw YT, Brand JS, Wark PA, Amiano P, Balkau B, Barricarte A, Boeing H, Fonseca-Nunes A, Franks PW, Grioni S, Halkjaer J, Kaaks R, Key TJ, Khaw KT, Mattiello A, Nilsson PM, Overvad K, Palli D, Quirós JR, Rinaldi S, Rolandsson O, Romieu I, Sacerdote C, Sánchez MJ, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van der A DL, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Wareham NJ; InterAct Consortium. Age at menarche and type 2 diabetes risk: the EPIC-InterAct study. Diabetes Care. 2013 Nov;36(11):3526-34. Impact Factor: 7.735. Q1: Endocrinology & Metabolism.

1.Títol del projecte: Prevención de las recaídas mediante ejercicio, dieta y control de peso en pacientes con cáncer de mama.
Ref.: PI12/00335
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III
Duració:  2013-2016
Subvenció: 145.200€
Investigador principal: Antonio Agudo

2.
Títol del projecte: Susceptibilidad genética al cáncer gástrico: validación y caracterización de genes y variantes identificadas en la cohorte Europea EPIC.
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)
Duració
:  2013-2016
Subvenció: 72.600€
Investigador principal: Núria Sala Serra 

3.
 Títol del projecte: Reduction of breast cancer recurrences through weight control, and a diet andphysical activity intervention: a feasibility study.
Organisme: Asociación Española Contra el Cáncer (AECC)
Duració:  2012-2013
Subvenció: 18.000€
Investigador principal: Antonio Agudo

4.
 Títol del projecte: Iron status and gastric cancer risk in the EPIC-EURGAST study.
Ref.: 428
Organisme: WCRF
Duració:  2012-2014
Subvenció: 166.957€ 
Investigador principal: Paula Jakszyn 

5.
 Títol del projecte: Determinantes de la homeostasis y sobrecarga de hierro y riesgo de cáncer gástrico en el estudio EPIC-EURGAST.
Ref.: PI11/01486.
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)
Duració:  2012-2014
Subvenció: 62.617€
Investigador principal: Paula Jakszyn

6.
 Títol del projecte: (IIG) Biomarkers of Acrylamide Exposure and Risk of Endometrial and Ovarian Cancers: A Molecular Epidemiologic Study in the European Prospective Investigation in Cancer and Nutrition (EPIC) Cohort.
Ref.: 6022
Organisme: WCRF
Duració:  2012-2014
Subvenció: 287.610€
Investigador principal: Eric J Duell 

7.
 Títol del projecte: Acrylamide biomarkers and cancer in the EPIC cohort.
Ref.: PI11/1473.
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)
Duració
:  2012-2014
Subvenció: 98.917€
Investigador principal: Eric J Duell 

8.
 Títol del projecte: Identificación de factores genéticos, ambientales y de expresión fenotípica asociados a la progresión de lesiones precursoras del cáncer gástrico: estudio coordinado español de seguimiento.
Ref.: PI10/01089
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)
Duració
:  2010-2013
Subvenció: 153.065,00€
Investigador principal: Carlos A. González 

9. Títol del projecte: Redes Temáticas de Investigación Cooperativa en Salud. RTICCC
Ref.: RD12/0036/0018
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)
Duració:  2013-2016
Subvenció: 81.592,50 €
Investigador principal: Carlos A. González 

10. Títol del projecte: Redes Temáticas de Investigación Cooperativa en Salud. RTICCC
Ref.: RD06/0020/0091
Organisme: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)
Duració:  2006-2013
Subvenció: 80.400,00€
Investigador principal: Carlos A. González 

11. 
Títol del projecte: Grup d’Etiologia i Patogènia del Càncer
Ref.: 2009SGR939
Organisme: AGAUR – Generalitat de Catalunya
Duració:  2009-2013
Subvenció: 42.640€
Investigador principal: Carlos A. González

Data d'actualització:  16.04.2014